<unk>  is a sphingosine 1-phosphate receptor modulator that is FDA approved for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.   Common adverse reactions include headache, hypertension, and transaminase increases.
Siponimod
Belinostat
Casopitant
Laquinimod
Aflibercept
Reteplase
Caplacizumab
Nebacumab